Rob Dillard

DocwireNews

Many older adults fail to place a high importance on factors recommended by guidelines to individualize diabetes treatment, according to a <a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2751248">study</a> published in JAMA Internal Medicine.In this cross-sectional national survey study that included 818 participants (mean age, 74, 53.7% male, 67.7% white) participants place into one of two vignettes: one about adding and the other about removing diabetes medications from treatment plans. Participants rated the importance of 7 factors (diabetes duration, established diabetes complications, other health conditions, life expectancy, risk of adverse effects, cost, and treatment effort) in these treatment decisions using binary (yes/no) responses and the best-worst scaling method to quantify the factors&rsquo; relative importance. Subsequently, participants answered questions on how different levels of each factor were associated with aggressiveness of diabetes treatment.According to the results of the study, a total of 410 participants answered questions about adding medicine, whereas 408 participants answered questions about stopping medicine. Of the 7 factors to consider for adding a diabetes medication to the treatment plan, the number who deemed each factor important ranged from 197 (45.6%) to 263 (62.8%). Conversely, those same factors were considered important by only 29 (8.4%) to 146 (37.7%) of participants when deciding to discontinue use of a diabetes medication. In both cases, the study subjects perceived the risk of adverse effects as the most important factor. In contrast to current guideline recommendations, most participants believed that patients with longer disease duration (498 [60.1%]), more established complications (632 [75.6%]), and greater number of other health conditions (545 [67.5%]) should receive more aggressive diabetes treatment.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
This is why we need patient participation on CPGs&hellip; Patient Perceptions of Diabetes Guideline Frameworks for Individualizing Glycemic Targets <a href="https://t.co/wWtOJr2u3R">https://t.co/wWtOJr2u3R</a>
&mdash; Doreen Rabi, M.D. (@doreen_rabi) <a href="https://twitter.com/doreen_rabi/status/1173736421338730501?ref_src=twsrc%5Etfw">September 16, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>The authors wrote in their conclusion that &ldquo;when considering treatment aggressiveness, many older adults weighted several factors in the opposite direction than suggested by the guidelines. Individualizing diabetes care in older adults will require effective communication regarding the benefits and consequences of making changes to treatment plans.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Older adult perceptions on DM. Pts "believed that patients with longer disease duration, more established complications, and more other health conditions should receive more aggressive treatment". This is unfortunately how the medical system works too&hellip; <a href="https://t.co/xNeXCI4NRO">https://t.co/xNeXCI4NRO</a>
&mdash; Sandra Shi (@shisadoctor) <a href="https://twitter.com/shisadoctor/status/1173760212295147520?ref_src=twsrc%5Etfw">September 17, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
What factors should influence prescribing and <a href="https://twitter.com/hashtag/deprescribing?src=hash&amp;ref_src=twsrc%5Etfw">#deprescribing</a> of diabetes meds? Patients' opinions are far from those recommended by guidelines and should inform how discussions occur. Great piece by Nancy Schoenborn &amp; Cynthia Boyd <a href="https://t.co/B0JFdqscoK">https://t.co/B0JFdqscoK</a> <a href="https://t.co/k6ZZ68qgpM">pic.twitter.com/k6ZZ68qgpM</a>
&mdash; Mike Steinman (@MikeSteinman) <a href="https://twitter.com/MikeSteinman/status/1173821223005896709?ref_src=twsrc%5Etfw">September 17, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Many Older Adults Fail to Place High Importance on Diabetes Treatment Guidelines

Diabetes

Many older adults fail to place a high importance on factors recommended by guidelines to individualize diabetes treatment, according to a study published in JAMA Internal ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe